|
Name |
Bipolarisorokin N
|
| Molecular Formula | C33H48O6 | |
| IUPAC Name* |
8-[[4-(6-formyl-1,7-dimethyl-4-propan-2-yl-8-bicyclo[3.2.1]oct-6-enyl)-2-hydroxybut-3-enoyl]oxymethyl]-1,7-dimethyl-4-propan-2-ylbicyclo[3.2.1]oct-6-ene-6-carboxylicacid
|
|
| SMILES |
CC1=C(C=O)C2C(C(C)C)CCC1(C)C2C=CC(O)C(=O)OCC1C2C(C(=O)O)=C(C)C1(C)CCC2C(C)C
|
|
| InChI |
InChI=1S/C33H48O6/c1-17(2)21-11-13-32(7)19(5)23(15-34)28(21)24(32)9-10-26(35)31(38)39-16-25-29-22(18(3)4)12-14-33(25,8)20(6)27(29)30(36)37/h9-10,15,17-18,21-22,24-26,28-29,35H,11-14,16H2,1-8H3,(H,36,37)/b10-9+/t21-,22-,24+,25+,26-,28-,29+,32+,33+/m1/s1
|
|
| InChIKey |
AFJGMOLXDHXYFP-YNGDCHNLSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 540.74 | ALogp: | 6.0 |
| HBD: | 2 | HBA: | 5 |
| Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 100.9 | Aromatic Rings: | 4 |
| Heavy Atoms: | 39 | QED Weighted: | 0.209 |
| Caco-2 Permeability: | -5.056 | MDCK Permeability: | 0.00001630 |
| Pgp-inhibitor: | 0.981 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.013 |
| 30% Bioavailability (F30%): | 0.89 |
| Blood-Brain-Barrier Penetration (BBB): | 0.028 | Plasma Protein Binding (PPB): | 96.90% |
| Volume Distribution (VD): | 0.672 | Fu: | 1.71% |
| CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.692 |
| CYP2C19-inhibitor: | 0.167 | CYP2C19-substrate: | 0.897 |
| CYP2C9-inhibitor: | 0.251 | CYP2C9-substrate: | 0.131 |
| CYP2D6-inhibitor: | 0.016 | CYP2D6-substrate: | 0.148 |
| CYP3A4-inhibitor: | 0.462 | CYP3A4-substrate: | 0.858 |
| Clearance (CL): | 5.234 | Half-life (T1/2): | 0.035 |
| hERG Blockers: | 0.025 | Human Hepatotoxicity (H-HT): | 0.229 |
| Drug-inuced Liver Injury (DILI): | 0.746 | AMES Toxicity: | 0.029 |
| Rat Oral Acute Toxicity: | 0.193 | Maximum Recommended Daily Dose: | 0.412 |
| Skin Sensitization: | 0.125 | Carcinogencity: | 0.224 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.012 |
| Respiratory Toxicity: | 0.939 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005681 | ![]() |
0.839 | D0X7XG | ![]() |
0.230 | ||
| ENC005679 | ![]() |
0.532 | D01CKY | ![]() |
0.227 | ||
| ENC005678 | ![]() |
0.528 | D0W5LS | ![]() |
0.224 | ||
| ENC005680 | ![]() |
0.514 | D0G5CF | ![]() |
0.224 | ||
| ENC005686 | ![]() |
0.440 | D0Y7LD | ![]() |
0.222 | ||
| ENC005687 | ![]() |
0.429 | D0X4RS | ![]() |
0.220 | ||
| ENC002278 | ![]() |
0.398 | D0G8OC | ![]() |
0.219 | ||
| ENC003555 | ![]() |
0.373 | D02CJX | ![]() |
0.218 | ||
| ENC001779 | ![]() |
0.367 | D05RXI | ![]() |
0.216 | ||
| ENC004002 | ![]() |
0.319 | D0V2JK | ![]() |
0.211 | ||